X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.globenewswire.com//news-release/2024/02/01/2821780/0/en/FDA-Issues-Reminder-of-Non-Substitution-of-PEDMARK-sodium-thiosulfate-injection-for-Pediatric-Patients-Receiving-Cisplatin.html
https://www.fiercepharma.com/manufacturing/accord-healthcare-restarts-production-cancer-drug-cisplatin
https://news.bms.com/news/corporate-financial/2023/European-Medicines-Agency-Validates-Bristol-Myers-Squibbs-Application-for-Opdivo-nivolumab-in-Combination-with-Cisplatin-Based-Chemotherapy-for-the-First-Line-Treatment-of-Adult-Patients-with-Unresectable-or-Metastatic-Urothelial-Carcinoma/default.aspx
https://www.onclive.com/view/petrylak-provides-perspective-on-the-nationwide-cisplatin-carboplatin-shortage
https://endpts.com/cisplatin-carboplatin-shortages-raise-questions-about-impact-on-clinical-trials/
https://www.fiercepharma.com/pharma/fda-clears-more-chemotherapy-imports-chinas-qilu-amidst-shortage-key-cancer-meds
https://endpts.com/fda-to-import-more-of-cancer-drug-from-china/
https://endpts.com/fda-inspection-at-india-pharma-at-center-of-the-cisplatin-shortage-cites-multiple-quality-issues/
https://www.fiercepharma.com/manufacturing/fda-allow-temporary-overseas-production-shore-supplies-chemo-drug
https://www.globenewswire.com/news-release/2023/04/11/2644211/0/en/Abstract-Evaluating-Allarity-s-DRP-Companion-Diagnostic-for-Cisplatin-Accepted-at-2023-ASCO-Annual-Meeting.html
https://www.prnewswire.com/news-releases/nanopharmaceutics-inc-announces-the-end-of-patient-recruitment-for-the-national-cancer-institute-nci-sponsored-phase-3-clinical-study-in-advanced-stage-cervical-and-vaginal-cancers-with-cisplatin-during-radiation-therapy-with--301666297.html
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-fennecs-hearing-loss-therapy-2022-09-21/
https://www.prnewswire.com/news-releases/innovent-and-lilly-jointly-announce-the-approval-of-tyvyt-sintilimab-injection-by-china-nmpa-in-combination-with-chemotherapy-as-first-line-treatment-for-esophageal-squamous-cell-carcinoma-301570972.html
https://www.globenewswire.com/news-release/2022/05/16/2444016/0/en/Junshi-Biosciences-Receives-NMPA-Approval-of-sNDA-for-Toripalimab-in-Combination-with-Paclitaxel-and-Cisplatin-in-First-Line-Treatment-of-Advanced-or-Distant-Metastatic-Esophageal-.html
https://www.globenewswire.com/news-release/2022/01/18/2368484/28235/en/Rafael-Pharmaceuticals-Announces-Ongoing-Successful-Enrollment-and-Opening-of-Additional-Sites-for-Phase-2-Clinical-Trial-of-CPI-613-Devimistat-in-Combination-with-Gemcitabine-and-.html
https://www.prnewswire.com/news-releases/innovent-releases-the-orient-31-phase-3-study-first-interim-analysis-results-of-sintilimab-plus-byvasda-bevacizumab-biosimilar-injection-and-chemotherapy-in-patients-with-egfr-mutated-nonsquamous-non-small-cell-lung-cancer-who-p-301429490.html
https://www.globenewswire.com/news-release/2021/11/01/2324277/33333/en/Coherus-and-Junshi-Biosciences-Announce-FDA-Acceptance-of-BLA-Filing-for-Toripalimab-for-Treatment-of-Nasopharyngeal-Carcinoma.html
https://www.globenewswire.com/news-release/2021/08/25/2286471/28235/en/Rafael-Pharmaceuticals-Announces-the-Successful-Completion-of-Phase-1b-Clinical-Trial-and-Initiates-Phase-2-for-CPI-613-devimistat-in-Combination-with-Gemcitabine-and-Cisplatin-in-.html
https://www.globenewswire.com/news-release/2021/06/22/2250760/0/en/Fennec-Pharmaceuticals-Announces-FDA-Acceptance-of-New-Drug-Application-Resubmission-for-PEDMARK.html
https://www.globenewswire.com/news-release/2020/11/30/2136875/0/en/Final-Data-from-the-Phase-Ib-Study-of-Acelarin-plus-Cisplatin-in-Patients-with-Advanced-Biliary-Tract-Cancer-Published-Online-Ahead-of-Print-in-The-Oncologist.html
https://www.globenewswire.com/news-release/2020/05/18/2035239/0/en/Galera-Therapeutics-to-Host-Virtual-KOL-Event-on-Cisplatin-Induced-Chronic-Kidney-Disease.html
https://www.globenewswire.com/news-release/2020/05/05/2027874/0/en/NuCana-Announces-Re-Opening-of-Global-Phase-III-Study-of-Acelarin-Plus-Cisplatin-in-Patients-with-Biliary-Tract-Cancer-NuTide-121.html
https://www.globenewswire.com/news-release/2020/04/29/2024568/0/en/Fennec-Announces-Proposed-Public-Offering-of-Common-Shares.html
https://markets.businessinsider.com/news/stocks/nanobiotix-provides-updates-on-clinical-development-continuity-in-the-context-of-the-covid-19-crisis-1029110502
https://www.globenewswire.com/news-release/2020/01/28/1976017/0/en/Otonomy-Presents-Preclinical-Results-for-GJB2-Gene-Therapy-Collaboration-and-Cisplatin-Otoprotection-Program.html
https://www.globenewswire.com/news-release/2020/01/28/1976017/0/en/Otonomy-Presents-Preclinical-Results-for-GJB2-Gene-Therapy-Collaboration-and-Cisplatin-Otoprotection-Program.html
https://www.globenewswire.com/news-release/2020/01/28/1976388/0/en/Akcea-and-Ionis-report-positive-topline-phase-2-study-results-of-AKCEA-ANGPTL3-LRx.html
https://www.globenewswire.com/news-release/2020/01/06/1966381/0/en/BridgeBio-Pharma-s-QED-Therapeutics-Receives-Fast-Track-Designation-for-Infigratinib-in-Adults-with-First-Line-Advanced-or-Metastatic-Cholangiocarcinoma-and-Orphan-Drug-Designation.html
https://www.biospace.com/article/releases/merck-receives-positive-eu-chmp-opinion-for-two-new-regimens-of-keytruda-pembrolizumab-as-first-line-treatment-for-metastatic-or-unresectable-recurrent-head-and-neck-squamous-cell-carcinoma-/?s=95
https://www.businesswire.com/news/home/20191016005264/en/Results-STELLAR-Trial-Tumor-Treating-Fields-Chemotherapy/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==
https://endpts.com/roches-tecentriq-excels-in-another-lung-cancer-study/
https://www.fiercepharma.com/marketing/astrazeneca-s-imfinzi-hits-survival-goal-tees-up-small-cell-lung-cancer-i-o-fight-roche
https://www.fiercebiotech.com/medtech/novocure-nets-approval-for-its-tumor-treating-fields-therapy-mesothelioma
https://www.prnewswire.com/news-releases/clinical-data-presented-from-pivot-02-study-of-bempegaldesleukin-nktr-214-with-nivolumab-in-metastatic-urothelial-carcinoma-patients-at-the-2019-asco-genitourinary-cancers-symposium-300796751.html
Market Place
Share 
